Atlas Trials

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

Clinical trial NCT03007407 · COMPLETED

Trial details

NCT number
NCT03007407
Sponsor
NSABP Foundation Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2017-07-31
Primary completion
2019-04-18
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.